Neurodegenerative disorders and type 2 diabetes are global epidemics compromising the quality of life of millions worldwide, with profound social and economic implications. Despite the significant differences in pathologymuch of which are poorly understood -these diseases are commonly characterized by the presence of cross-b amyloid fibrils as well as the loss of neuronal or pancreatic b-cells. In this review, we document research progress on the molecular and mesoscopic self-assembly of amyloid-beta, alpha synuclein, human islet amyloid polypeptide and prions, the peptides and proteins associated with Alzheimer's, Parkinson's, type 2 diabetes and prion diseases. In addition, we discuss the toxicities of these amyloid proteins based on their self-assembly as well as their interactions with membranes, metal ions, small molecules and engineered nanoparticles. Through this presentation we show the remarkable similarities and differences in the structural transitions of the amyloid proteins through primary and secondary nucleation, the common evolution from disordered monomers to alphahelices and then to b-sheets when the proteins encounter the cell membrane, and, the consensus (with a few exceptions) that off-pathway oligomers, rather than amyloid fibrils, are the toxic species regardless of the pathogenic protein sequence or physicochemical properties. In addition, we highlight the crucial role of molecular self-assembly in eliciting the biological and pathological consequences of the amyloid proteins within the context of their cellular environments and their spreading between cells and organs. Exploiting such structure-functiontoxicity relationship may prove pivotal for the detection and mitigation of amyloid diseases.
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Introduction
Molecular self-assembly is a ubiquitous phenomenon across all living systems: from the polymerization of tubulins and actins into microtubules and actin filaments, to the organization of lipids, transmembrane/peripheral proteins and ion channels into cell membranes, to the assembly of DNA and histones into chromatin fibers and solenoids, and to the aggregation of peptides and proteins intra-or extracellularly evolving from functional monomers to toxic oligomers, amyloid fibrils and plaques. Fundamental to these processes are interactions between the molecular constituents of the assemblies, as well as interactions between the molecular constituents and their associated chaperones, ligands, ions, molecular complexes and organizations, driven by kinetic and thermodynamic processes to elicit desirable biological functions or malfunctions and diseases.
In this review, we attempt to draw parallels from the atomic and mesoscopic structures of five major classes of amyloid proteins in self-assembly, namely, amyloid-beta (Ab), tau, alpha-synuclein (aS), prions, and human islet amyloid polypeptide (IAPP), as well as the biological and pathological endpoints these assemblies elicit in host systems (Fig. 1) . The amyloid aggregation of these peptides has been implicated in Alzheimer's, Parkinson's, prion diseases and type 2 diabetes mellitus, or generically referred to as neurodegenerative disorders and His research focuses on understanding the structure, dynamics, and function interrelationship of biomolecules and molecular complexes. He T2D that debilitate hundreds of millions of people worldwide. In vitro, such peptides/proteins fibrillate on the timescales of tens of minutes for IAPP to days for Ab and aS, characterized by a sigmoidal kinetic curve consisting of a lag phase, an elongation phase, and a saturation phase. 1 The lag phase is where nucleation is initiated through protein misfolding and where intrinsic seeds and/or oligomers are formed, the elongation phase corresponds to the addition of monomers to growing protofilaments, while the saturation phase is where protofilaments associate through self-assembly to render amyloid Scope of the present review, highlighting protein self-assembly, its biological and pathological implications, theranostics and prevention. Ab: amyloid-beta; IAPP: islet amyloid polypeptide; aS: alpha-synuclein; PrP: prion protein; CD: circular dichroism spectroscopy; FTIR: Fourier transform infrared spectroscopy; ThT: thioflavin T assay; NMR: nuclear magnetic resonance; HD: hydrogen-deuterium exchange; SDSL: site directed spin labelling; EPR: electron paramagnetic resonance; TEM: transmission electron microscopy; AFM: atomic force microscopy. ER: endoplasmic reticulum; ROS: reactive oxygen species. Tom's research focuses on the application of polymer science and nanotechnology to therapeutic applications. Tom is a Fellow of the Australian Academy of Science. He has authored 450+ peerreviewed papers and his work has been cited in excess of 29 000 times.
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fibrils. In addition to primary nucleation, secondary nucleation through the combination of both monomeric and aggregated species is also feasible. 2, 3 It has been suggested that the amyloid state is perhaps available to any polypeptide chain [4] [5] [6] [7] [8] [9] and represents the energetically most favorable state even compared to native proteins. 1 In vivo, however, the development of amyloids and plaques in the brain or pancreatic islets often takes decades, or B10 000 times longer. Such drastic differences in fibrillization may originate from the crowded hierarchical cellular environments, where amyloid proteins are synthesized and then translocate and spread through inter-and intra-molecular assembly, chaperoned by proteins (e.g. insulin for IAPP) or modulated by pH and ionic strength. Accordingly, while the main purpose of this review is to highlight the structure-function-toxicity triangle of a selected few amyloid proteins, another goal of this presentation is to draw the reader's attention from focusing exclusively on amyloid proteins to the environments of the culprits at large, which undoubtedly also contribute to the pathologies of the amyloid diseases. Such perspective may prove beneficial to the development of mitigation strategies and theranostics against amyloidogenesis that has become increasingly perilous to modern society.
In terms of content, this review consists of 6 sections: Section 1 offers an introduction to protein self-assembly and amyloid diseases; Sections 2-5 review the structure, function and toxicity characteristics of Ab, tau, IAPP, aS and prions, loosely following their increasing number of amino acids (residues); Section 6 provides a summary. Ab and tau, despite their great contrast in chain length, both contribute to the AD pathology and hence are presented together. Although Ab is slightly longer than IAPP in chain length, Ab is the most studied of all amyloid proteins 10 and is therefore discussed in an early section of this review.
Ab, tau and Alzheimer's disease
The hallmark of Alzheimer's disease (AD) is the accumulation of toxic aggregates that impair synaptic function and induce cognitive decline. The first reported occurrence of cognitive disorder linked to AD was in 1907 by Alzheimer, who observed two types of abnormality in a brain autopsy that he attributed to be the cause of an unusual type of dementia. 11 The discovery of neuritic plaques (or miliary foci) and neurofibrillary tangles (NFTs) was immediately linked to the dystrophic neuronal process, and later Ab fibrils 12, 13 and hyperphosphorylated tau tangles 14 were isolated and characterized (and proposed to cause dementia).
Characterizations of the monomeric forms of the molecules found in these neurotoxic deposits have led to greater understanding of the pathways leading to AD, with a particular focus on the structure-function relationship between aggregates and neurotoxicity. However, almost all drugs tested thus far in clinical trials have failed or shown limited impact on AD. Tau is a neuronal protein associated with microtubules and may regulate neuron morphology. There are six main tau isoforms in the brain and central nervous system (CNS). The longest human isoform has 441 residues with a high proportion of phosphorylable residues (serine and threonine) and a low proportion of hydrophobic amino acids. Tau protein in solution is considered an intrinsically disorder protein (IDP) and behaves as a random coil, 15 although modifications by phosphorylation may lead to an increase in a-helix or b-sheet regions. Aggregation of totally or partially disordered proteins is associated with many neurodegenerative diseases, including AD. 16 However, the molecular mechanism of aggregation and the structure of the aggregated form remain controversial. Tau is mainly an axonal protein but in AD and other tauopathies it is also present at dendritic spines and may play a toxic role. The tau hypothesis of AD considers that excessive phosphorylation of tau protein can result in the self-assembly of tangles of paired helical filaments (PHFs) and straight filaments which are involved in the pathogenesis of AD and other tauopathies. These NFTs are insoluble structures that impair axonal transport and lead to cell death. The molecular structures of PHFs and tau protein are not well defined. NMR data 17 have revealed that 343 of the 441 amino acids in tau are disordered with six segments of the sequence displaying propensity to form b-strands, three segments showing poly-Pro helices and two segments with a transient a-helix structure. In particular, aggregation of tau is believed to be strongly associated with two short residue sequences: [18] [19] [20] [21] the first in the third repeat fragment (R3, i.e. VQIVYKPVDLSKVTSKCGSLG-NIHHK) of the microtubule binding domain of tau, VQIVYK, or the mutant VQIINK, in the second repeat fragment. The aggregation of the R3 fragment has been extensively studied in the presence of polyanions, such as heparin, pointing at the formation of fibrillar structures with similar features as those assembled from pristine tau protein. 22 In the absence of heparin, however, the same R3 fragment has been shown to self-assemble into giant amyloid ribbons of remarkable aspect ratios. 23 The tau protein is a highly dynamic structure. An NMR study of a peptide derived from tau showed that phosphorylation stabilized the a-helix structure, 24 suggesting a possible higher content of a-helices in hyperphosphorylated tau in PHFs. Tau protein can form dimers, oligomers and larger aggregates and fibrils. However, in this review we focus on the Ab peptide rather than tau aggregates, as greater structural details are available for the former.
Role of APP and production of Ab
Ab peptides are produced by an intrinsic cleavage of the amyloid precursor protein (APP) that is an integral membrane protein encoded on chromosome 21 by the APP gene. 25 It is accepted that patients with trisomy 21 (Down syndrome) overexpress APP and develop AD-like senile plaques in their brain. 26, 27 Yet, the physiological function of APP remains uncertain, mostly because APP is part of a gene family with overlapping function (e.g. producing the amyloid precursor-like proteins APLP1 and APLP2) and is subject to various postexpression modifications. 28 Still, only APP generates the Ab fragment. APP modulates critical features in brain development since APP knock-out mice are viable but exhibit reduced body weight and brain mass 29 with increased brain levels of copper, 30 cholesterol and sphingolipid. 31 Interestingly, reintroducing the APP ectodomain, which is produced by cleavage of the membrane-anchored APP, improved cognitive function and synaptic density 32, 33 and acted as an apoptosis modulator through caspases activations. 34 The intracellular C-terminal domain also has a functional role in sorting APP and, in particular, the highly conserved YENPTY cytoplasmic sequence is prone to interaction with other proteins, such as X11 and Fe65, which are postulated to regulate APP internalization. 35 The location and sequence of the proteolytic cleavage of APP are critical to AD. APP is primarily translocated to the cell surface (short residence time) where a-secretase and then gsecretase produce APPsa, p3 and AICD fragments, which are not amyloidogenic. However, when APP is relocated through endocytosis (rapid turnover due to the YENPTY sequence) into endosomes containing the b-secretase (also called BACE1) and the g-secretase, then APPsb, the toxic Ab peptides and AICD fragments are produced (Fig. 2) . BACE1 is an aspartyl protease that has optimum efficiency at pH 4.5. 36 Interestingly, acid pH can promote greater aggregation rate of Ab peptides 37 due to the protonation state of the three histidines (His6, His13 and His14), and also attenuate lysosomal degradation of Ab peptides. 38 Furthermore, if APP is relocated to the trans Golgi network instead of the ER, BACE1 can produce N-truncated Ab peptides which are prone to rapid pyroglutamylation. 39 These species have been characterized as highly toxic 40 and found in intracellular, extracellular and vascular Ab deposits in AD brain tissue, 41 while unmodified peptides are primarily located in endosomal compartments and are eventually exocytosed into the extracellular space. It is noteworthy that intracellular pools of Ab peptides are pointed as the most toxic species causing the death of neurons. 42, 43 The physiological function of these Ab peptides, usually 39-43 residues in length, is unconfirmed. However, during excitatory neuronal activity, an increase in excretion of Ab peptides is observed 44 with the effect of downregulating excitatory synaptic transmission. 45 Thus, Ab peptides are an important modulator of memory, since inhibition of peptide production impairs learning. 46 Ab(1-40) is the most abundant Ab isoform found in its soluble form in plasma, cerebrospinal fluid and brain interstitial fluid 47 but is also a major component in amyloid plaques. Interestingly, the level of the fastaggregating isoform Ab(1-42) is a biomarker for detecting amyloid pathologic changes in the brain and cerebral vessels 48 and, moreover, the relative Ab(1-42)/Ab(1-40) ratio is markedly increased in AD. 49 Overall, both the concentration and location of Ab peptides are critical for brain function, thereby complicating therapeutic strategies against AD.
Atomic structures of Ab40 & Ab42, post-modifications and amyloid fibrils
Ab peptides vary in length due to the multiple cleavage sites recognized by the secretases, but the most abundant species are Ab and Ab , whose sequences are shown in Fig. 3 . Furthermore, Ab peptides can be degraded by proteases such as insulin degrading enzymes, 50 neprilysin 51 and cathepsin B, 52 which render the fragments non-amyloidogenic. Ab peptides can be subject to post-translational modifications including pyroglutamate formation (Glu3, 11 and 22), 53 phosphorylation (Ser8 and 26), 54 dityrosine formation (Tyr10) 55 and oxidation (Met35) 56 (see Fig. 3 ).
The Ab peptide primary sequence exhibits two stretches of hydrophobic residues (17-21 and 32 until C-terminus), which are predicted to adopt a b-sheet conformation. 57 Two turn regions are also predicted between residues His6 and Ser8, and between Asp23 and Asn27. Finally, the hydrophilic patches between Asp1 and Lys16 and between Glu22 and Lys28 have either b-sheet or a-helical propensity. 58, 59 A missing piece in the AD puzzle is the secondary structures of Ab peptides immediately after cleavage by the g-secretase.
Firstly, b-CTF is likely to remain structured after cleavage by BACE1, at least up to the transmembrane a-helical segment that contains part of Ab sequence (Ala28 until C-terminus). Secondly, cleavage by the g-secretase occurs at intra-membrane and Ab peptides have a demonstrated affinity for lipid membranes. Thus immediate trafficking is unclear: do Ab peptides remain in, on or away from the membrane interface? Since lipid membranes modulate the aggregation kinetics, 60 this step could play a critical role in subsequent trafficking and AD pathology. Several Ab peptide structures have been compiled in the past two decades, 61 with a consensus that an unstructured to b-sheet transition first occurs followed by a seeded aggregation process to form oligomeric structures that eventually proceeds to mature amyloid fibrils of 70-120 Å in diameter and an indeterminate length according to electron microscopy. 62 Determination of the initial structure of Ab peptides in native conditions is challenging since the rapid self-aggregation rate accompanied by poor solubility prevents the application of high-resolution techniques such as solution NMR. 72 Indeed, the multistep kinetics of amyloid assembly comprise a lag phase, during which little or no fibril material is formed, followed by an exponential growth of b-sheet-rich aggregates that propagate into amyloid fibrils. 1 Increasing evidence suggests that the native partly helical intermediates form early nucleation seeds during the lag phase. 73 The intramolecular interactions stabilizing the b-sheet structure are shown in Fig. 3 . In both Ab isoforms, the turn conformation is stabilized by hydrophobic interactions and by a salt bridge between Asp23 and Lys28. Many side chain contacts are observed, in particular between Phe19 and Ile32, Leu34 and Val36, and between pairs Gln15-Val36 and His13-Val40. 57, 74 Phosphorylation of Ab peptides, however, does not modify their primary unstructured conformation but does lead to a 5-fold reduction in the lag phase due to a faster transition to bsheet structures, more efficient nucleation and a greater number of oligomeric seeds. 75 N-truncated and/or pyroglutamatemodified Ab peptides form b-sheet structures 76 with faster aggregation kinetics than the corresponding full-length peptides, which suggests they could be potential seeding species for aggregate formation. More remarkably, the pyroglutamatemodified Ab peptides also inhibit the full-length peptide fibrillogenesis and lead to a greater content of small oligomeric species 77 that have been demonstrated as most toxic.
Ab aggregation kinetics and amyloid fibril formation
Knowledge of Ab aggregation kinetics and mechanisms has been acquired mainly through in vitro studies using synthetic peptides. The kinetics of fibril formation depends on several intrinsic and extrinsic factors. The primary sequence of the peptide modulates the propensity to aggregate into mature fibrils. Post-modifications promote faster aggregation kinetics, as does the Ab(1-42) sequence compared to the shorter Ab(1-40) peptide. Extrinsic factors, such as interaction with lipid membranes, can have either a slowing or accelerating effect, rendering determination of a generic model nontrivial. The lag phase is a period of slow self-aggregation and structural change, likely from helical to b-sheet structures, and characterized by a combination of multiple nucleation and elongation phases 2, 78, 79 leading to a large number of oligomeric species. Primary nucleation is a fast process (milliseconds) producing the first seeds that are elongated further into fibrils by the addition of monomers. The formation of new aggregates is thought to be dominated by a second nucleation phase where existing fibrils are fragmented to expose new seeds either co-aggregating or recruiting monomers. Interestingly, changes in the primary nucleation rate do not affect the elongation phase while secondary nucleation and fragmentation modify the lag and elongation phases. 80 The difference in aggregation rate between the amyloid peptide species, however, may be related to their primary nucleation rate. In fact, Ab(1-40) monomers, in comparison to Ab , exhibit a slower nucleation rate inducing (or caused by) a shift towards nucleation on the fibril surface rather than accumulation of small oligomeric species. 79 These fibril-catalyzed secondary nucleation and elongation processes could be a critical difference in relation to the trafficking and toxicity of the Ab peptide variants. 81 Notably, measuring the kinetics of aggregation is challenged by the difficulty in sample preparation, 81 especially with regard to starting an experiment without any preformed seeds or a controlled amount of seeds.
The elongation phase is due to the addition of oligomers/ monomers onto protofibrils (Fig. 4) or association of protofibrils, in competition with fragmentation of the protofibrils. It is often typified by the half time of the aggregation reaction where monomers and protofibrils are near equimolar. However, intrinsic and extrinsic factors modulate the stability of the oligomeric species and can template seeds, thereby shifting the kinetic rate towards primary nucleation with a faster aggregation rate. The stationary phase represents a steady state where the monomer concentration has reached an equilibrium value and the fibrils are the prevalent species. Notably, AFM studies show that fibrils of different amyloid-forming peptides with diverse macroscopic structures/polymorphism (i.e., ribbon-like versus nanotube-like packing) have a similar Young's modulus, and thus all Ab peptides are anticipated to exhibit similar mechanical strength. 82 Intrinsic and extrinsic factors also play a critical role in the modulation of the lag and elongation phases by changing the concentration of free monomers in solution and/or acting as seeding interfaces. The molecular factors influencing the aggregation kinetic of Ab peptides are various and difficult to assign to a particular microscopic event (primary versus secondary nucleation, fragmentation, etc.), although some properties are more straightforward to correlate; for instance, the effect of pH as electrostatic interactions mediate either attraction or repulsion of the monomers. However, several studies have shown that Ab peptides form polymorphic fibrils depending on growth conditions and various oligomeric aggregates. Thus it is unlikely that amyloid fibrils formed in vitro resemble those in the brain. Tycko and co-workers 84 seeded fibril growth from brain extract and used solid-state NMR and electron microscopy to gain structural details of the Ab fibrils. Using tissue from two AD patients they found a single Ab40 fibril structure for each patient emphasizing the critical role of the seeding process. The molecular structure for Ab40 fibrils from one patient (Fig. 5 ) revealed differences from in vitro fibrils. The authors then proposed that fibrils may spread from a single nucleation site and that structural variations may correlate with variations in AD.
In comparison with Ab40, Ab42 is more neurotoxic and their differences in behaviour may be due to intrinsic differences in structure. An atomic resolution structure of a single form of Ab42 amyloid fibrils has been derived from high field magic angle spinning NMR spectra. 85 The structure shows a dimer of Ab42 molecules, each containing four b-strands in an S-shaped amyloid fold (Fig. 6 ). The dimer is arranged to form two hydrophobic cores, capped by a salt bridge at the end with a hydrophilic outer surface. The monomer interface within the dimer shows contacts between M35 of one molecule and L17 and Q15 of the second. Intermolecular constraints show that the amyloid fibrils are parallel in-register. Interestingly, Ishii and co-workers obtained a similar S-shape arrangement (Fig. 6 ) using ultra-fast spinning solid-state NMR techniques. 86 Although knowing atomic details of the fibril may be useful for drug design, nevertheless, the oligomer species are generally accepted as the toxic species. 87 2.5 Extrinsic factors modulating Ab structure, aggregation kinetic and toxicity 2.5.1 Ab-metal interactions. The role of transition metals in AD is highly debated and a recent literature search using meta-analysis and systemic review methodologies identified a widespread misconception that iron and, to a lesser degree, zinc and copper levels are increased in AD brain. 88 99 The lipid membrane interface itself is proposed to be a heterogeneous nucleation site, which modulates Ab peptide folding kinetics and pathways by reducing the seeding mechanism to a two-dimensional system. 100, 101 To date, there is a consensus that lipid bilayer plays a role in Ab aggregation and may be involved in neurotoxicity. Different model membranes influence the structure and size of Ab fibrils based on the charge and hydrophobicity of the membrane. spectroscopy and solid-state NMR. 103 In contrast to the mature, lesstoxic Ab fibrils, the membrane-attached oligomer appeared to form a b-barrel or 'porin'-like structure (also refer to Fig. 15b in Section 4 for aS), which may account for a mechanism for Ab toxicity. Cholesterol is proposed to be related to AD pathology although cholesterol stabilizes phospholipid bilayers against Ab. 104 Lipid 'rafts' or domains in the membrane enriched in cholesterol and sphingolipids could modulate Ab production, aggregation and toxicity. 105 Sanders and co-workers 106 showed that the C99 segment of APP bound to cholesterol and proposed that APP might act as a cholesterol sensor critical for the trafficking of APP to cholesterolrich membrane domains. Cholesterol increases the thickness of phospholipid bilayers and may influence the proteolytic processing of APP and proportion of Ab40 to Ab42 produced. Lipid membranes are also susceptible to oxidative stress, as mentioned above as a mechanism for neurodegeneration in AD. 98 
Ab toxicity and Alzheimer's disease
The physiological markers of AD are progressive cognitive decline, synaptic loss, presence of extracellular b-amyloid plaques and intracellular neurofibrillary tangles ultimately leading to neuronal cell death and a massive brain cell mass loss. To date, there is no drug that can prevent AD neurodegeneration probably because many pathways are activated during the uncontrolled production of Ab peptides, although several candidates are in ongoing clinical trials. Indeed, it has been demonstrated that Ab peptides accumulate at synapses, thereby disrupting the whole neuronal network. 107 More specifically, complex interactions between Ab peptides and both synaptic ion channels and mitochondria alter their physiological activities. Ab peptides and, more particularly, the oligomers of Ab have affinity for the glutamate 108 and acetylcholine 109 receptors, mediating the influx/efflux rate of critical mediators such as calcium ions. Ab-mediated deregulation of these receptors -particularly NMDAR and AMPAR -has been linked to the impairment of plasticity and degeneration of synapses during AD. 110 The observation that Ab oligomers are able to co-localize within mitochondria has exposed another potential neurotoxic pathway. 111 Ab oligomers are able to alter the function of proteins involved in the mitochondrial fusion/fission process, which causes their fragmentation leading to the loss of neuron viability. 112 Moreover, accumulation of Ab peptides in synaptic mitochondria has been shown to decrease mitochondrial respiration and key respiratory enzyme activity, elevate oxidative stress, compromise calcium-handling capacity, and trigger apoptotic signals. 113, 114 Finally, intracellular accumulation of Ab peptides drastically reduces the lysosomal efficiency in removing damaged organelles and unfolded proteins, such as tau. 115 Better understanding of the cell biology of the downstream effects of Ab oligomers may uncover potential therapeutic targets for the prevention of AD.
Mitigation strategies and theranostics
With increased knowledge of the mechanism of fibril formation from the cleavage of APP to the kinetic modulation by extrinsic factors, several strategies to mitigate AD have emerged. Stabilizing the monomeric form of Ab peptides is a direct strategy to limit the formation of oligomeric species. Peptides that specifically interact with the pro-aggregating domains have been developed, as recently shown with a cyclopeptide, to inhibit Ab amyloidogenesis. 116 Antibody-based immunotherapy is another strategy to mitigate AD. For instance, a promising candidate, aducanumab, has been shown highly selective against aggregated Ab, inducing significant reduction of insoluble and insoluble Ab population and slowing clinical decline, although the outcome of ongoing phase 3 clinical trials is needed to confirm these promising observations. 117 The affinity of Ab peptides for transition metals was seen as another area for potential development of AD therapeutics, but so far chelators, such as Dpenicillamine, have not produced any clinical improvement. 118 After drugs (e.g. bapineuzumab and solanezumab) which sought to lower existing Ab loads had failed, increasing attention was paid to BACE drugs that interfere with the process that creates Ab. However, Merck recently closed its trial for the BACE inhibitor, verubecestat, in mild-to-moderate AD after concluding that the drug had little chance of success. 119 A particular focus has been to decrease the production of apparently toxic Ab peptides by inhibiting BACE1 activity. 120 For instance, the cholesterol-rich endosomal environment, which promotes selective processing of APP by BACE1, has been pursued as a target using a membrane-anchored BACE1 transition-state inhibitor linked to a sterol moiety to generate highly effective BACE1 inhibitors. 121 Treatment with BACE inhibitor IV, which does not change the APP concentration level, was shown to prevent mitochondrial abnormalities caused by Ab. 122 Reducing the activation of caspases, such as caspase 3, can improve neuronal growth and decrease abnormal tau species, which may be an interesting therapeutic pathway for the treatment of AD.
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Since the approval of memantine in 2003, no new AD drug candidate has passed the FDA approval, with an alarming failure rate of 99.6%, the highest in all serious disease research programs. 124 A growing strategy in integrating therapeutics and personalized diagnostics has recently emerged as a promising route. Based on nanomedicine, small molecules -necessary to overcome prerequisite to cross the brain blood barrier -have been developed to label and simultaneously inhibit oligomerization of Ab peptides. 125 The term theranostic has thus been coined to characterize these new inhibitor-biomarkers, many based on scaffolds of fluorescent probes such as ThT, to detect fibril formation in vivo and alter their accumulation. 126 These new strategies have been made possible by improved understanding of the assembly mechanism of Ab at the molecular level, which will continue to guide rational drug design against AD.
IAPP and type 2 diabetes
Function of IAPP
Human islet amyloid polypeptide (IAPP, a.k.a. amylin) is a 37-residue peptide hormone co-secreted with insulin from pancreatic b-cell islets. The IAPP physiology has been recently reviewed by Westermark et al. 127 Briefly, the peptide is synthesized from a 67-residue precursor peptide, proIAPP, by proteolysis and posttranslational modifications, such as the C- terminal amidation and a disulfide bond formation between residues 2 and 7 ( Fig. 7a) . 128, 129 Both IAPP and insulin are regulated by similar factors with a common regulatory promoter motif. 130 Before secreting to the circulation, IAPP is stored together with insulin inside the b-cell granules at high concentrations. IAPP functions as a synergistic partner of insulin to control the blood glucose level by slowing down gastric emptying, inhibiting digestive secretion, and promoting satiety. 131, 132 IAPP is also known to play a role in bone metabolism along with calcitonin and calcitonin gene-related peptides.
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A hallmark of type 2 diabetes (T2D) is the formation of IAPPenriched amyloid plaques found in the pancreas of patients. Insulin resistance in T2D leads to increased production of insulin and also IAPP by b-cells because of their shared synthesis and secretion pathways. Since IAPP is one of the most amyloidogenic peptides known, over-production of IAPP in b-cells promotes the accumulation of toxic aggregates. Other studies also suggested that insufficient process of proIAPP and accumulation of intermediately processed peptides might promote the formation of amyloid fibrils, but the detailed molecular mechanisms remain unclear. The disease progression is marked by bcell death and loss of b-cell functions, resulting in insulin deficiency and diabetic dependence on external insulin sources.
Atomic structures of IAPP and IAPP amyloid fibrils
Structural characterization of IAPP monomers is extremely challenging due to the high aggregation propensity of the peptide. By reducing IAPP aggregation with detergent micelles, solution NMR studies have been used to study the structure of IAPP monomers. [137] [138] [139] It has been shown that SDS micelles stabilize IAPP in a highly helical form ( Fig. 7b-d) . At low pH, the peptide assumes an extended alpha-helix. At neutral pH, the peptide has been found to form a kinked helix around residue H18. Such structural difference is likely due to the electrostatic interaction of the protonated His18 at low pH with the anionic SDS. Combing low pH, low temperature, and low peptide concentrations to hinder IAPP aggregation in solution, an NMR study has recently revealed that the N-terminus of IAPP remains alpha-helical while the Cterminus is unstructured, which is consistent with molecular dynamics (MD) simulations of isolated IAPP monomers. 140 The fibril aggregates of IAPPs share the same characteristic cross-beta structures of known fibrils. 141 Although the atomic structure of full-length IAPP amyloid fibrils is not available, several model structures have been proposed based on various experimental methods. Using constraints derived from solidstate NMR, Tycko et al. proposed a U-shaped fibrils model where residues 8-17 and 26-37 form two beta-sheets ( Fig. 7e) . 134 Based on X-ray microcrystallography structures of two short peptides, Eisenberg et al. reconstructed a similar fibril model with main differences in the side-chain packing (Fig. 7f ). 135 Recently, EPR studies of disulfide-reduced IAPP led to a different fibril model (Fig. 7g) , where the peptide still adopted a U-shape with two strands separated by a longer distance. 136 The two strands in a single peptide had to be staggered with respect to each other to have the appropriated inter b-sheet packing and distances.
Mesoscopic structure of IAPP amyloids
The morphology of IAPP amyloid fibril has been studied by both TEM and AFM. 142, 143 IAPP fibrils at the mesoscopic scale displayed significant structural polymorphism, including ribbon-like, sheet-like and helical fibril morphologies (Fig. 8) .
The ribbons and sheets were formed by lateral association of 5 nm wide protofibrils (Fig. 8a) . Most of the fibrils were found in left-handed coil morphology with cross-over periodicities of either B25 nm or B50 nm (Fig. 8b ). Based on these observations, Goldsbury et al. proposed that the building block of IAPP fibrils is the 5 nm protofibril which can either self-assemble laterally into ribbon-like or sheet-like arrays or coiled fibrils. 143 The atomic models of IAPP fibrils are consistent with these TEM and AFM observations.
IAPP toxicity and type 2 diabetes
Mounting evidence suggests that IAPP aggregation and the related toxicity are associated with T2D. IAPP variants from diabetes-prone primates and cats formed amyloid aggregates readily in vitro, while those from diabetes-free rodents and pigs featured significantly lower aggregation propensities. 144 A naturally-occurring polymorphic S20G mutation rendered IAPP more aggregation prone; 145 and an Asian subpopulation carrying this mutation is subjected to early onset of T2D. 146 IAPP aggregated rapidly upon transplanting human islets into nude mice, and the aggregation process occurred before the recurrence of hyperglycermia and was correlated with b-cell death. 147, 148 Transgenic mice expressing human IAPP variant started to develop diabetes. 149 Moreover, as with other amyloid proteins, 150, 151 IAPP amyloid aggregates are toxic to pancreatic islet cells. 152 Therefore, amyloid aggregation of IAPP is related to b-cell death in T2D. 153 3.4.1 Oligomers vs. amyloids. Amyloid aggregation is a nucleation process, featuring a characteristic all-or-none sigmoidal kinetics. The final mature amyloid fibrils have been found relatively inert and have no significant cell toxicity. In contrast, freshly dissolved IAPP has been found to be highly toxic to islet cells and also cause membrane instability in vitro, 154 where the small and soluble aggregation intermediates of IAPP are expected to accumulate before the rapid fibril growth. IAPP oligomers have also been found to disrupt cell coupling, induce apoptosis, and impair insulin secretion in isolated human islets. 155 Additional evidence includes transgenic mice studies, 149, 156 where amyloid deposits were not always observed under optical microscopy in animals starting to show diabetic symptoms, and there was a lack of autocorrelation between beta cell loss and amyloid deposits in these models. 157 In addition, inhibition of the formation of insoluble IAPP aggregates but not oligomers by either small molecules 158 or proteins 159 did not reduce the cytotoxicity. Hence, these results among many others led to the toxic oligomer hypothesis in T2D. 160, 161 As the aggregation intermediate species, IAPP oligomers are not well-defined and are extremely challenging to characterize due to their transient and heterogeneous nature. Many in vitro studies support the accumulation of helical intermediates populated along the aggregation pathway. [162] [163] [164] It has been suggested that the N-terminal helixes of soluble IAPPs (Fig. 7d ) are amphiphilic and hydrophobic interactions drive the helix association, which in turn increases the local concentration of the C-terminus containing the amyloidogenic sequence 20-29. 165 Both discrete molecular simulations (DMD) of IAPP 166 The difference is possibly due to the enhanced sampling method -replica exchange 167 -used in the MD study, which reduced the free energy barrier of helix unfolding in the N-terminus. Further research is necessary to fully understand the structure and dynamics of IAPP oligomers in order to identify the toxic species and the molecular mechanism of IAPP toxicity. 3.4.2 The endogenous inhibition of IAPP aggregation. IAPP is highly aggregation prone and readily forms amyloid fibrils in vitro at mM concentrations within hours. 168 However, before its secretion to the bloodstream IAPP is stored inside b-cell granules at mM concentrations for hours without apparent formation of toxic aggregates in healthy individuals. 169 Therefore, the physiological environment inside b-cell granules natively inhibits the formation of toxic IAPP aggregates while disruption to the native inhibition environment may lead to amyloid aggregation of IAPP, causing b-cell death. Islet b-cell granules have a distinct cellular environment. 170 First, the pH value inside the granules is 5.5, which is below the physiological pH of 7.4. Second, b-cell granules have one of the highest concentrations of Zn 2+ ions in the entire human body. The high concentration of zinc in b-cell granules, maintained by a bcell-specific zinc transporter-ZnT8, 171 is believed to be important for the efficient storage of insulin in b-cell granules: zinc coordinates the formation of insulin hexamers, which form insulin crystals as the dense core of b-cell granules. 172 Third, beside IAPP peptides b-cell granules also have other molecules in large quantities, including insulin and proinsulin C-peptide. Insulin is cosecreted with IAPP by b-cells at a ratio of B100 : 1 in healthy individuals, and such a high insulin-to-IAPP ratio is reduced to B20 : 1 in T2D patients. 173 The C-peptide is a part of the proinsulin sequence connecting A-and B-chains of insulin. Proteaseprocessing of proinsulin results into mature insulin and Cpeptide with an equal molar concentration inside b-cell granules.
Low pH. Inhibition of IAPP aggregation at low pH has been observed in vitro. At low pH, an increase in the lag time and a decrease in the growth rate of IAPP fibrillization was observed. 174, 175 The electrostatic repulsion between IAPPs with protonated histidine18 (His18) is responsible for inhibiting the self-association of IAPP at low pH, 176 supported by DMD simulations of IAPP dimerization with and without protonation of His18. 177 However, since the pH value inside b-cell granules is close to the isoelectric point of His18 174, 178 and a significant portion of IAPP is still unprotonated, interactions of IAPP with other granule components are necessary for natively inhibiting the peptide amyloid aggregation at high concentrations.
Insulin. In vitro experiments have revealed that insulin is a potent IAPP aggregation inhibitor, which can significantly slow down aggregation at sub-stoichiometry concentrations. 180 Several studies, including peptide mapping, 181 IMS-MS combined with MD simulations, 182 and DMD studies 140 suggested that the B-chain of insulin can bind IAPP. Computational studies with atomistic DMD simulations showed that both insulin monomers and dimers (but not the zinc-bound hexamer as the IAPPbinding interface is buried) could bind IAPP monomer and inhibit IAPP self-association by competing with the amyloidogenic regions important for aggregation, subsequently preventing amyloid aggregation ( Fig. 9a and b) . The preferred binding of insulin with the amyloidogenic region in the beta-strand conformation (Fig. 9a) suggests that insulin can also cap the fibril growth, consistently with the observed sub-stoichiometric inhibition of IAPP aggregation by insulin. Comparing to high zinc concentrations where insulin is insoluble in the crystal form, 183 zinc-deficiency due to loss-of-function mutations of ZnT8 shifts the insulin oligomer/crystallization equilibrium toward soluble monomers and dimers, which can efficiently inhibit IAPP aggregation and reduce T2D risk in the subpopulation carrying these mutations. 184 However, since IAPP is found almost exclusively in the soluble halo fraction of b-cell granules while insulin is mostly insoluble in the core, the balance of other granule components such as Zn 2+ and/or C-peptide co-localized with IAPP appears crucial for maintaining the native state of IAPP.
Zinc. In an early study by Steiner and co-workers where ZnCl 2 was added to B250 mM IAPP solution, aggregation promotion was observed. 185 This promotion effect leveled off till B1 mM zinc ion was added, but no data at higher salt concentrations was reported. In later experimental studies, IAPP aggregation inhibition was observed at low zinc concentrations (5 and 10 mM, but relatively high zinc/IAPP stoichiometry), followed by a partial recovery of aggregation at very high stoichiometry (B50-100). 186, 187 A ''two-site binding'' model, where a high affinity binding with His18 stabilized non-aggregating oligomers but an unknown weaker secondary binding promoted amyloid fibril formation, was proposed. 187 However, this model cannot account for aggregation-promotion at low ion/protein stoichiometry 185 (e.g., in the case of 10 mM of IAPP there was a single data point with increased aggregation at B25 mM of zinc 186 ). Combining DMD simulations with experimental characterizations, 179 Govindan et al. developed an alternative model that was consistent with the experimentally-observed concentration-dependent effect of zinc on IAPP aggregation. At low zinc/IAPP stoichiometry, the IAPP oligomers cross-linked by zinc were aggregation-prone due to high local peptide concentrations (Fig. 9c) . As ion/protein stoichiometry increased, each IAPP tended to bind only one zinc ion at His18. The electrostatic repulsion between the bound zinc ions (+2e) inhibited IAPP aggregation, similarly to the low pH condition where IAPP aggregation was inhibited by protonated His18 (+1e). 176 With zinc concentration kept increasing, the screening effect due to high salt concentrations reduced electrostatic repulsion, and allowed for the aggregation to recover (Fig. 9d) . 186, 187 C-peptide. Without zinc binding, C-peptide is disordered in water and weakly helical in trifluoroethanol (TFE) solution. The peptide contains five acidic amino acids. Alanine scan coupled with MS experiments suggest that all these acidic amino acids bind zinc ions and the binding is 1 : 1 in stoichiometry. 189 It has been found that zinc-binding may induce structural changes. 190 It was hypothesized that multiple negatively charged acidic amino acids in C-peptide allow the binding with multiple IAPP peptides, locally increasing IAPP concentration and subsequently promoting IAPP aggregation. Upon binding zinc, C-peptide adopts specific secondary and tertiary structures with reduced net charges, which might bind and stabilize IAPP peptides in the aggregation-incompetent state. In addition, other granule molecules including proIAPP 191 and proInsulin may also contribute to native inhibition of IAPP aggregation and cytotoxicity in beta-cells and are subject to future investigations.
IAPP-membrane interactions.
It has been proposed that IAPP exerts cytotoxicity by membrane disruption. 154, 192, 193 The positively charged IAPP can bind anionic cell membranes and lipid micelles, and the peptide conformational and aggregation propensities change upon binding also depending on the membrane curvature. 192 Binding of IAPP with small micelles was found to stabilize the peptide in helical conformation (Fig. 7) , while absorption of IAPP on flat membrane accelerated the peptide aggregation. 194 Using a lipophilic Laurdan dye for examining MIN6 cell membranes upon exposure to freshly dissolved IAPP as well as mature amyloid fibrils, Pilkington et al. found that all species, especially fresh IAPP, enhanced membrane fluidity and caused losses in cell viability. 195 The cell generation of ROS, however, was the most pronounced with mature amyloid fibrils. This study suggests a correlation of cytotoxicity with changes in membrane fluidity rather than ROS production. The exact mechanism by which IAPP oligomers disrupt the cell membrane is under active investigation. Pore formation by amyloid peptides has been suggested important for membrane disruption. [196] [197] [198] The amyloid pore model is strongly supported by single channel recordings of IAPP on planar membranes. 196, 199, 200 A detergent-like mechanism has also been advocated, where the mosaic-like opening and closing of transient defects within the membrane (also see Fig. 15d in Section 4 for aS) was supported by AFM studies showing largescale defects in the lipid bilayer upon prolonged exposure to IAPP. 201 However, the strong correlation between fibril formation and membrane disruption by this mechanism 202 is inconsistent with the toxic oligomer hypothesis. Recently, biophysical measurements in conjunction with cytotoxicity studies showed that nonamyloidogenic rat IAPP was as effective as IAPP at disrupting standard anionic model membranes under conditions where rat IAPP did not induce cellular toxicity, suggesting that there is no direct relationship between disruption of model membranes and induction of cellular toxicity. 203 Therefore, the connection between IAPP cytotoxicity and membrane disruption remains inconclusive.
Mitigation strategies and theranostics
As with other amyloid diseases, [204] [205] [206] inhibition of IAPP aggregation is an attractive therapeutic strategy to prevent b-cell death 207 and halt the progression of diabetic conditions in T2D. 232 however, pharmacological applications of these polyphenols are limited due to some common issues, such as their poor water solubility. 233 Several studies have examined the anti-amyloid mechanisms of small molecules and NPs. For example, IMS-MS experiments showed that EGCG exerted an inhibitory effect on IAPP aggregation through direct binding of EGCG to the peptide 215 and alternating the aggregation pathways. 228 Using simulations of the amyloidogenic segment of IAPP, resveratrol was found to bind and prevent the lateral growth of the fibril-like b-sheets.
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In another work, resveratrol was found to bind weakly to IAPP and reduce inter-peptide contacts. 236 A recent computational study showed that resveratrol altered the structure of an IAPP pentamer, 237 which was modelled by the amyloid fibril structure derived from solid-state NMR. 134 By modelling the effects of polyphenols like resveratrol and curcumin on the initial selfassociation and aggregation of IAPP in DMD simulation, 234 Nedumpully-Govindan et al. showed that these polyphenols inhibited IAPP aggregation by promoting ''off-pathway'' oligomers with the hydrophobic polyphenols forming the core (Fig. 10a) . The peptides were stabilized in the aggregationincompetent helix-rich state by burying their hydrophobic residues inside the core and exposing the hydrophilic residues. Graphene oxide nanosheets displayed strong inhibition effects on IAPP aggregation and associated cytotoxicity because strong binding affinity rendered the peptides to bind with the nanosheets rather than between themselves. 225 OH-terminated polyamyloidoamine (PAMAM-OH) dendrimers inhibited IAPP aggregation and cytotoxicity, where the polymeric NPs encapsulated and stabilized monomeric IAPP in their hydrophobic interior (Fig. 10b) . 224 In general, these inhibitors all reduced the population of the oligomeric species, thereby reducing IAPP toxicity.
Alpha-synuclein and Parkinson's disease
Function of alpha-synuclein
Alpha synuclein (aS) is a 140-residue small protein highly concentrated in presynaptic terminals, 238 making up as much as 1% of all proteins in the cytosol of brain cells. Small traces of aS are also found in the heart, gut, 239 muscles and other tissues, reminiscent of the confounding bodily distributions of Ab and IAPP beyond their purported origins. In the intraneuronal space, aS assumes an equilibrium between an unfolded monomeric conformation and a membrane-bound state that is rich in alpha helices. 240 The precise physiological role of aS is unclear, but is relevant to the modulation of neurotransmitter dopamine release, ER/Golgi trafficking, and synaptic vesicles. 241 The membrane-bound aS influences lipid packing and induces vesicle clustering through physical and physicochemical interactions, while aS in the multimeric form has been shown to promote SNARE complex assembly during synaptic exocytosis. 240 Aggregated aS mediates dopaminergic neurotoxicity in vivo. 244 However, the precise mechanisms by which aS lends toxicity to host cells remain unclear. Pathologically, aS is a major component of Lewy bodies and neurites, the intracellular protein aggregates first identified by Spillantini et al. in 1997 (Fig. 11 ) 242 and hallmarks of Parkinson's disease (PD), Parkinson's disease dementia (PDD) and dementia with Lewy bodies (DLB). Compared with the ambiguous pathology of aS, the neuritic pathology of b and g synuclein homologs does not appear widespread, and both neuroprotective and neurotoxic potentials of b synuclein have been reported. 245 
Atomic structures of alpha-synuclein and alpha-synuclein amyloid fibrils
The sequence of aS is encoded by the SNCA gene and can be divided into three distinct domains: (a) the amphipathic Nterminal domain (1-60), which contains consensus KTKEGV repeats and has alpha-helical propensity, (b) the central domain or the non-amyloid-beta component (NAC) that is highly hydrophobic and amyloidogenic, and (c) the acidic Cterminal domain (96-140) which contains negatively charged and proline residues to afford protein flexibility but no apparent structural propensity. 246 High resolution ion-mobility mass spectroscopy has revealed that HPLC-purified aS is autoproteolytic, giving rise to a number of small molecular weight fragments upon incubation. In particular, the fragment of residues 72-140 contains majority of the NAC region and aggregates faster than full-length aS. 247 These autoproteolytic products may serve as intermediates or cofactors in the aggregation of aS in vivo.
The atomic structures of fragmental and full-length aS in the fibrillar form have been elucidated over the past decade (Fig. 12) . Using quenched HD exchange Vilar et al. identified five b-strands within the fibril core comprising residues 35-96 and with solid-state NMR spectroscopy the presence of b-sheet secondary structure within the fibril core of residues 30-110. 241 This study has further detailed the mesoscopic features of aS fibrils, as we will visit in the next sub-section.
Based on micro-electron diffraction Rodriguez et al. revealed small crystal structures of the toxic NAC core (68-78, or NACore) and the preNAC segment (47-56) of aS, at spatial resolution of 1.4 Å (Fig. 13a) . 248 The NACore strands stacked in-register into b-sheets. The sheets were paired, forming stericzipper protofilaments as observed for other types of amyloidogenic proteins. Notably, each pair of the sheets contained two water molecules, and each was associated with a threonine side chain within the interface. X-ray fiber diffraction patterns further revealed a similarity of the NACore to full-length aS fibrils. 248 In a more recent study, Tuttle et al. established the atomic structure of full-length aS fibrils based on 68 spectra, using 2D and 3D ssNMR. 249 The fibrils were collected from cell culture and shown to adopt a b-serpentine arrangement (Fig. 13b-e) . The fold exhibited hydrogen bonds in register along the fibril axis, orthogonal to the hydrogen bond geometry in a standard Greek-key motif unseen for other fibrils (Fig. 13d) . 249 The innermost b-sheet contained amyloidogenic residues 71-82, while the sidechains in the core were tightly packed (Fig. 13e) . Compact residues facilitated a close backbonebackbone interaction: A69-G93 bridged the distal loops of the Greek key, and G47-A78 rendered a stable intermolecular salt bridge between E46 and K80. Hydrophobic sidechain packing among I88, A91 and F94 established the innermost portion of the Greek key. Residues 55-62 were disordered, consistent with that reported by Comellas et al. 250 Collectively, the steric zippers, glutamine ladder and intermolecular salt bridge contributed to the structural complexity and stability of the fibril. However, it remains uncertain whether such atomic structure reflects that of aS fibrils extracted directly from PD patients.
Mesoscopic structure of alpha-synuclein amyloids
The morphology of aS fibrils has been examined with AFM 251-253 and cryoelectron microscopy. 241 in attempt to reconcile the morphological and mechanical data observed for two distinct fibril species of E46K, a mutant of aS. Nonetheless, according to the HAM, protofilaments are established by the nucleated polymerization kinetic model, in which the protofilaments elongate by the addition of monomeric, partially folded intermediates to their growing ends. The protofilaments then interact with each other to form protofibrils, each consisting of twisted 2-3 protofilaments, and two protofibrils entwine to form mature fibrils and, eventually, plaques. The driving force for such stepwise assembly is both electrostatic and hydrophobic. The HAM model predicts the occurrence of periodicity for protofilaments and fibrils, which assume twisted morphologies. Such periodicity is driven by a balance between mechanical forces dominated by the protofilament elasticity and electrostatic forces due to the distribution of hydrophobic regions and charge along the protofilament backbone, 253 as well as by the inherent chirality of constituting amino acids and b-sheets/helices of the fibrils. The average heights of aS protofilaments and fibrils were 3.8 nm and 6.5 nm, respectively, while the periodicity of aS fibrils ranged from 100-150 nm as determined by AFM (Fig. 14a) . 253 These parameters are consistent with immunoelectron microscopy of filaments extracted from the brains of patients with DLB and multiple system atrophy, 262 and agree with high-resolution cryoelectron microscopy where twisted protofilament of B2 Â 3.5 nm in boundaries and 120 AE 10 nm in periodicity were observed leading to the proposal of a folded aS fibril model (Fig. 14b) . 241 The crosssection of individual aS monomers in the fold was trapezoid instead of circular, resulting in a two-fold increase in moment of inertia ). 263 Though not substantiated, such non-circular packing of monomers could also hold true for other b-sheet folded proteins. 261, 263 In addition, curly aS fibrils prepared by filtration-like steps during aggregation possessed a persistence length of 170 nm, while straight aS fibrils from amyloids. Natively unfolded aS undergoes a transition to partially folded intermediates prior to fibril formation. 265 Such partially folded conformations are favored by mutations 266 or changes in pH, ionic strength and temperature and are thought to be critical intermediates in the transition to amyloid fibrils. 253 Clearly, such dynamic transition has an important bearing on aS toxicity, as evidenced by a body of literature focused on the complex roles of aS oligomers and amyloids. The aggregation of aS follows a nucleation polymerization pathway involving prefibrillar species of remarkable conformational plasticity, 267 both transient and stable. Specifically, it is postulated that aS aggregation takes place in the cytoplasma or in association with the cellular membrane. In the cytosol, soluble monomers interact to form unstable dimers, which develop into oligomers and, subsequently, fibrils. 268 The current understanding concerning aS toxicity follows the narrative of the ''toxic oligomer hypothesis'', 251 in that the oligomeric species are more toxic than the fibrillar form, 251, [269] [270] [271] [272] as similarly proposed for Ab [273] [274] [275] [276] [277] [278] [279] and IAPP. 280 However, due to the different structural characteristics and aggregation rates, different cellular environments, as well as prion-like cell to cell spreading and crosstalk of proteins of different origins and pathologies, this generalization remains putative. 281, 282 In an early in vitro study, Conway et al. compared the rates of disappearance of monomeric aS and appearance of fibrillar aS for wide-type and two mutant proteins A53T and A30P. 251 The differences between the trends suggested the occurrence of nonfibrillar aS oligomers. Using sedimentation and gel filtration chromatography, the researchers identified spheres (range of heights: 2-6 nm), chains of spheres (protofibrils), and rings/ annulars (heights: B4 nm) from fibrils (B8 nm in diameter) by AFM. For a comprehensive account of aS oligomers and their in vitro preparation protocols, readers may refer to a recent review by van Diggelen et al.
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Using attenuated total reflection-Fourier-transform infrared (ATR-FTIR) spectroscopy Celej et al. revealed that isolated aS oligomers adopted an antiparallel b-sheet structure, whereas fibrils assumed a parallel arrangement. 284 Notably, antiparallel b-sheet structures have also been reported for the oligomeric structures of Ab, b 2 -microglobulin and human prion peptide PrP82-146. 284 Such contrasting features in secondary structure between the oligomers and fibrils entail differences in conformational change, affinity and mode of interaction when binding with the cell membrane, further compounded by the differences in aspect ratio and surface hydrophobicity between the two species. The toxicities of aS oligomers and amyloid protein oligomers in general have been postulated as an inherent property. 285 Unlike amyloid fibrils, the oligomers share similar structural properties 273, 286 and possess higher portions of random coils and helical structures. Consequently, the exposed hydrophobic surfaces of the oligomers could mediate interactions with intracellular proteins to trigger aberrant cellular pathways. Celej et al. found that purified aS oligomers spheroidal and polydisperse (10-60 nm), while aS fibrils were unbranched of 6-10 nm in diameter and micrometers long when examined under electron microscopy. 287 These isolated oligomers were onpathway intermediates sharing the same structural motif with other prefibrillar oligomers and possessing no canonical cross-b fibril structure. 284 Curiously, the aS oligomers were recognized by A11 antibody, which also targeted the oligomeric but not monomeric or fibrillar forms of Ab, prions, and IAPP. 273, 288 While it remains debatable whether aS oligomers are intermediates in the process of amyloid formation, or precursors to fibrils, or byproducts of fibril elongation, or associated with a pathway of aggregation different from the standard amyloid fibrillization, 269 there is little ambiguity that aS oligomers are toxic, as validated by in vitro and animal models. strong functional association with synaptic vesicles and its cellto-cell spreading. 291 From a biophysical standpoint such interactions may be understood as a manifestation of the structural attributes of aS (sequence, charge and hydrophobicity), as well as the changing properties of aS from soluble and disordered monomers to soluble and less random oligomers, and to waxy and highly ordered fibrils and plaques.
Research concerning protein-membrane interaction should take into consideration of two convoluting aspects: protein aggregation modulated by a model lipid bilayer or cell membrane, and membrane integrity perturbed by protein aggregation. Numerous studies have confirmed that lipid membranes can speed up the process of protein fibrillization due to the amphiphilicity of both interactants. 292, 293 Specifically, the N-terminal region of aS, containing 7 amphiphilic imperfect repeats each of 11-residues, can initiate electrostatic interaction with anionic lipid head groups. The NAC region of the protein can establish hydrophobic interaction with lipid fatty acyl tails to promote membrane partitioning. 294 Upon membrane exposure, the protein concentration at the membrane surface is abruptly increased due to the 3D to 2D transition. Consequently, protein conformational entropy is reduced to favor aggregation. 294, 295 Specifically, the rate of aS primary nucleation was enhanced by three orders of magnitude when exposed to small unilamellar vesicles (SUVs, 20-100 nm in diameter) of 1,2-dimyristoyl-sn-glycerol-3-phospho-L-serine (DMPS). 296 Upon adsorption onto lipid membranes, monomeric amyloid proteins adopt an a helical state, followed by a conversion to bsheet rich oligomers and amyloid fibrils modulated by the curvature and charge of the membranes, presence of metal ions, peptide to lipid ratio, and ganglioside clusters, cholesterols and lipid rafts. 299 aS assumes a fully extended a helical state coming into contact with larger vesicles, likely representative of the protein conformation in vivo. 300, 301 In contrast, smaller vesicles with greater curvatures and smaller surface areas are associated with proteins in bent a helices or antiparallel helix-turn-helix conformation to maximize protein-membrane binding. 293 A high peptide/lipid ratio favors protein crowding on the membrane surface to induce nucleation. 302 Binding of aS (isoelectric point of 4.74) 303 with membranes is elevated with increased acidic phospholipid content. [304] [305] [306] aS oligomers also show propensity for the liquid disordered phase of anionic vesicles. 307 The exact mechanism of aS association with lipid rafts is unclear, but is linked to the high lipid packing density of anionic head groups in the rafts. Such specific binding between aS and lipid rafts may be essential to both the normal cellular function of aS and its role in PD pathology. 299 Elevated levels of metal ions have been found in the substantia nigra of PD patients. 308 Addition ions to monomeric aS rapidly produced annular oligomers, 309 while divalent metal ions also enabled the clustering of aS on the surfaces of anionic 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho(1 0 -rac-glycerol)/ phosphatidylcholine bilayers. 306 It is possible that metal cations enabled the interaction of the likely charged C-terminus of aS and membranes through charge neutralization. Such strong metalhosting capacity of amyloid proteins has been utilized in entirely different contexts from amyloidogenesis, such as purification of wastewater and in vitro iron fortification using functional blactolglobulin amyloids.
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The adsorption of aS has been shown to compromise membrane permeability. 282 One mechanism proposed for such perturbation is pore formation by the protein oligomers (Fig. 15a-c) . 271, 284, 293, 297 In combination with biochemical and ultrastructural analysis, Tsigelny et al. revealed through MD simulations and docking that aS monomers, upon adsorption onto lipid membranes through their N-termini, assembled into homodimers of both propagating (head to head) and nonpropagating (head to tail) conformations. The propagating form docked on the membrane surface to recruit additional aS molecules, rendering pentamers and hexamers to form ringlike structures partitioning in the membrane. 313 Consistently, addition of stable aS oligomers has been shown to induce ionchannel activity (Fig. 15c) , 297 while Ca 2+ and dopamine exhibited much higher leakage rates than polymers of cytochrome c and fluorescein isothiocyanate-dextran from anionic vesicles in the presence of oligomeric A30P and A53T, two major aS mutations. 314 Under conditions in which vesicular membranes were less stable due to the lack of counter-ion Ca
2+
, aS permeation was less size selective and monomeric aS permeated via a detergent-like mechanism. 293 Another mechanism proposed for aS-membrane interaction is illustrated in Fig. 15d . 298 Here the presence of a supported lipid bilayer facilitates the conversion of aS from randomly structured monomers to alpha helices (top panel), which further aggregate into oligomers and fibrils while stripping lipids off the bilayer (middle and lower panels). Membrane thinning and depolarization, changing fluidity, lipid flip-flop, calcium leakage, and disruption of ionic homeostasis are plausible consequences of aS membrane adsorption, aS selfassembly, and aS assembly with membrane lipids, through hydrophobic and electrostatic interactions as well as lipid micellar encasing of the protein species (i.e., the carpet model 315 ). This mechanism is supported by experimental studies employing giant vesicles as well as reporters of ThT, calcein, Ca 2+ and fluorescence recovery after photobleaching, [316] [317] [318] [319] to name a few.
In close connection with aS toxicity and aS-membrane interaction, a body of literature has revealed links between aS oligomers and mitochondrial dysfunction, cytoskeleton deformation, enhanced ROS production, neuroinflammation, ER stress, as well as impaired protein degradation systems. [320] [321] [322] [323] [324] [325] [326] [327] [328] An analysis of wide-type aS and two mutational variants A30P and E46K interacting with synaptic-like SUVs suggested a mechanism by which a single aS binds to two different synaptic vesicles via the NAC to promote their assembly and vesicle clustering. 329 In addition, promotion of SNARE-complex formation has been found to be associated with aS assembly into high-order multimers upon their binding with plasma membranes, suggesting that aS may act as a SNARE chaperone at the presynaptic terminal against neurodegeneration. (Fig. 11a) . Multiple system atrophy (MSA) is a special type of synucleinopathy, since aS-positive inclusions are found in oligodendroglia instead of in neurons. In these diseases, aS pathology in the substantia nigra is closely correlated with motor symptoms and death of SN dopaminergic neurons stimulates the striatum. 282 The PD pathology involves progressive neuronal accumulation of aggregated aS, and formation of Lewy bodies affects various functional structures throughout the human nervous system to compromise movement. 330 Exogenous aS fibrils seeded Lewy body-and Lewy neurite-like inclusions in cell culture models, and direct neuron to neuron aS transmission throughout the brain propagated PD-like pathology. 291, 331, 332 Failure of the protein quality control systems, especially lysosomes, promoted accumulation of transmitted aS and inclusion formation. Cells exposed to neuron-derived aS displayed signs of apoptosis, such as nuclear fragmentation and caspase 3 activation, both in vitro and in vivo. 291 Inoculation of aS fibrils into wide-type non-transgenic mice seeded aggregation of endogenous mouse aS and reproduced key features of the neurodegenerative cascade. 249 A molecular level understanding of the pathological spreading of aS in PD is lacking, but growing evidence suggests its origin lies in protein self-assembly through templated seeding, where the imported aS aggregates catalyze the conversion of local soluble protein molecules into their aggregated forms. A recent study has revealed regulation of motor deficits and neuroinflammation by intestinal microbiota in a PD model, 239 suggesting a role for microbial signals in PD. 333 Multiplication of the protein aggregates by recruiting additional aS en route has been proposed as an additional mechanism to templated seeding, to ensure sustainable concentration of the aggregates spreading from cell to cell. 332 However, multiplication of aS at neutral pH has not been observed, pointing to the involvement of other cellular processes in enabling the prion-like aS spreading. The ambiguities concerning the natural state, toxicity and aggregation pathway of aS have hindered the development of mitigation and theranostics against PD. The current approaches, still very much in the incubation stage, aim at exploiting the structural, functional and toxicological properties of aS, or the self-assembly of the protein and its structural and pathological characteristics for therapeutic efficacy. 268 Stabilization of the native aS structure from misfolding is a logical strategy. This intervention may also help resolve the controversy concerning a tetrameric initial state of aS. 334 One promising approach to slow down aS synucleinopathies is to limit the role of extracellular aS in disease progression, from interfering with aS secretion to neuronal uptake. Removal of aS from the extracellular space to minimize inflammations may be achieved with immunotherapy, as immunization with human aS suppressed protein aggregation and decreased neurodegeneration in transgenic mice overexpressing the protein.
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The use of small molecules and mutation is another feasible approach for stabilizing oligomeric species and ameliorating toxicity. The antioxidation and anti-inflammatory properties of the small molecules -often polyphenols or their structural derivatives with the capacity of interfering with protein aggregation through competing H-bonding, hydrophobic interaction and p-stacking with the protein -may counteract the toxicity elicited by the oligomeric species. [338] [339] [340] The presence of small molecules and other aggregation antagonists may also reduce accessibility to the oligomers by environmental chaperones, ligands and molecular organizations, thereby driving the aggregation off pathway to halt aS pathology. 
Prions and prion diseases
Transmissible spongiform encephalopathies (TSEs), also known as prion diseases, are a family of rare fatal neurodegenerative disorders associated with prion protein (PrP), and arise in several mammalian species by sporadic, inherited, or infectious means. Kuru, Creutzfeldt-Jakob disease (CJD), Gerstmann-StrausslerScheinker (GSS), fatal familial insomnia (FFI) and fatal sporadic insomnia (FSI) are PrP-related human disorders, 341 whereas scrapie, bovine spongiform encephalopathy (BSE) and chronic wasting disease (CWD) are known sheep, 342 352 and have a b-enriched secondary structure.
353-355
The most distinct feature of TSEs, unique among diseases related to protein misfolding, is the infectivity of the pathogenic agent. Procedures that hydrolyze or modify proteins reduce scrapie infectivity, whereas procedures that alter nucleic acids have no effect. [356] [357] [358] [359] The ''protein-only hypothesis'' has now been widely accepted, [360] [361] [362] [363] contending that a protein structure can be replicated without the use of nucleic acids and the infectious pathogen is the misfolded PrP Sc . 356, 357, [360] [361] [362] [363] [364] [365] In addition, prion diseases progress in host without any sign of immune responses to a ''foreign infectious agent''. 341 When the protein requirement for infectivity was established, prions were defined as proteinaceous infectious particles that resisted inactivation by procedures that modified nucleic acids. 341 Since prion pathology and infectivity 366 are closely related to a protein existing in two different conformations, much research in the last decade has been dedicated to understanding the structures of native PrP C 367 and pathological Prp Sc . 368 PrP Sc is believed to act as a structural template, inducing conversion of other PrP C molecules into the pathological form. 341 Understanding PrP conformational structures is therefore essential for describing protein misfolding and the specific role of PrP in prion pathology.
Function of PrP
PrP is encoded by gene (PRNP) found in chromosome 20 (in human) 369 and expressed in many tissues, including the brain, circulating lymphocytes, heart, kidney, skin, digestive tract, endothelia, mammary gland and muscle. The physiological role of native PrP C remains unclear. 370 It has been shown that the protein is involved in several cellular processes including neuroprotection against excitotoxicity and serum starvation, 371 proliferation and cell-cell adhesion, 370, 372 formation of synapses 373 and ligand binding. 374, 375 PrP can protect cells against heavy metal overloading and subsequent oxidative stress by binding divalent ions of copper, zinc, manganese and nickel. 375 Due to the ability of PrP to modulate cell proliferation and apoptosis it is believed to play a role on cancer development. 376 Indeed, increased PrP C level has been found in gastric cancer, 377 colorectal cancer 378 and skin cancer.
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A common approach to study the function of PrP is using PrP knockout transgenic mice (Prnp À/À ). The major finding in Prnp
mice was the lack of developmental differences and resistance to prion diseases. 380 However, Prnp À/À mice have shown cognitive abnormalities 370 such as depressive-like behavior, anxiety-related disorders and alterations in circadian activity. 381 In addition, decreased spatial learning of Prnp À/À mice has been noticed. 382 Using three Prnp knockout mice lines Firestein and colleagues found that PrP C was important in the normal processing of sensory information by the olfactory system. 383 
Atomic structures of prions and prion amyloids
The atomic structures of full-length and truncated PrP C were mostly solved by NMR. [384] [385] [386] [387] [388] Notably, X-ray crystallography studies were restricted to the C-terminal domain of PrP, suggesting an intrinsic tendency of the protein to avoid crystallization. 389, 390 Proto-protein of human PrP (huPrP) is 253 residues long (Fig. 16a) . After translation to mature form, the first 22 residues are removed and the last 23 residues are cleaved off prior to the addition of a glycosyl phosphatidylinositol (GPI) anchor to Ser230. PrP is attached to the outer surface of the cellular membrane by a GPI anchor within the raft domains. The sequence of PrP is highly conserved amongst mammals: 391, 392 human PrP shares 99.2%, 94.9% and 92.8% of identical sequences with the proteins from chimpanzee, sheep and cow, respectively. PrP C has two regions with distinct structural and dynamical properties. 367 In mammals, depending on the organism, the Nterminus contains a variable number of amino-terminal octapeptide repeats with sequence PHGGGWGQ. Each octarepeat is able to generate a divalent metals-binding domain via nitrogen atoms in the histidine imidazole side-chains. 393 The Nterminus is up to residue 120 and this region has been shown to constitute a pH-dependent folding: at pH 4.5 it is flexibly disordered, 394 however at pH 6.2 residues 61-84 of the octarepeats adopt a loop and a b-turn like conformation. 386 In contrast, the C-terminus of PrP C is structured, containing three a-helices (H1, H2 and H3) and a short, two-stranded, antiparallel b-sheet (S1, S2) 367 ( Fig. 16b) . A disulphide bridge is between Cys179 and Cys214, which anchors H2 and H3 helices. This disulphide bridge is one of the major determinants of the tertiary structure of PrP. FTIR study of PrP secondary structure revealed 42% of a-helices, 3% of b-sheets, 32% of turns and 23% of coils, respectively. (Fig. 17a) . The authors constructed a trimeric model of PrP 27-30 from a study of 119 all-b folds globular proteins. PrP 27-30 is a protease-resistant 27-30 kDa core of PrP Sc (Fig. 16) , and it retains prion infectivity. 353, 397 According to the b-helical model the Nterminal residues of PrP 27-30 form left-handed b-helices that are horizontally stacked, whereas the C-terminus maintains ahelical secondary structure as in native PrP C . Larger aggregates are formed by vertically stacking of PrP trimers along the bhelical axis (Fig. 17a) . Based on MD simulations of PrP 27-30 conformational fluctuations under amyloidogenic conditions, DeMarco and Daggett proposed the b-spiral model 398 (Fig. 17b) . Similarly to the b-helical model the C-terminal a-helical characteristics of PrP C remain unchanged and natively unfolded N-terminus adopt a b-structure. The core structure is comprised of three short b-strands spanning 116-119, 129-132 and 160-164 residues. Surewicz and colleagues proposed the in-register b-sheet model of PrP Sc using site-directed spin labelling and EPR spectroscopy 399 ( Fig. 17c) . In contrast to the other models, they observed that the refolding of PrP C involved major refolding of the C-terminal a-helical region. According to this model PrP Sc structure possesses no a-helices, consisting mainly of single molecules stacked on top of one another with parallel, inregister b-strands. Using MD simulations, Caughey and colleagues suggested that linear PrP Sc fibrils possessed a parallel inregister b-sheet structure 400 ( Fig. 18e) .
In addition, a number of structures have been proposed for mammalian 401 and fungal 402 prion protein segments. It is difficult to determine which of the proposed models is the closest to the PrP Sc structure, as they were established based on low-resolution experimental data. The diversity of the models could originate from the specimens used. For example, Wille and colleagues compared natural brain-delivered PrP Sc and synthetic bacteria-expressed recombinant PrP (with the same sequence) amyloid structure and found substantial differences in structure, heterogeneity and infectivity. 403 In addition, the existence of PrP tertiary structural diversity and prion strains have been experimentally proven, [404] [405] [406] [407] [408] including the formation of new strains during the passage of prions through animals with different PrP sequences. 409, 410 For instance, multiple scrapie prion strains were isolated with different incubation times and neuropathology. 411 However, these prion strains were encoded by the same PrP primary structure and were propagated in mice with the same PrP gene. Despite this, limited proteolysis generated different PrP Sc fragments, suggesting that these prion strains possessed different conformations. 352 
Mesoscopic structures of prions
The morphology of prions has been examined with TEM [412] [413] [414] and AFM. 414 Usually PrP Sc isolated from brain appears as large amorphous highly insoluble aggregates (Fig. 18a) . Individual prion fibrils, termed prion rods (Fig. 18b) , are not always visible probably because of heavy surface glycosylation 415 (Fig. 18c) .
Each PrP monomer has up to two large sugar moieties linked to the N-terminus to obscure the fibril core. Deficiencies in glucans and GPI archorless PrP have been found suitable for analyzing the structural features of prion protofilaments (Fig. 18d) , while neither glycosylation 416, 417 nor the GPI anchor 348, 418 is required for the infectivity of PrP Sc .
Majority of PrP fibrils, either wild-type, anchorless, or of different strains, possess a twisted morphology. Prion fibrils can be either left-handed or right-handed, 414 consisting of two or more protofilaments. 412 However, some fibrils also contain straight, parallel protofilaments. 414 In addition, fibrils occasionally resemble celery stalks or half-pipes 414 (Fig. 18c) . In a recent study the gap previously thought to be the spacing between two protofilaments of celery stalk fibrils was assigned to represent the trough between the major hairpins. Accordingly, an in-register b-sheet PrP amyloid model was proposed. 400 The 424, 425 Less common ways of transmission in humans are surgical instruments and human derived growth hormones. 426 The clinical symptoms of PrP diseases originate from pathological changes in CNS such as vacuolization, astrogilosis and neuronal apoptosis. However, once prion replication in CNS reaches its peak, the PrP Sc is disseminated centrifugally to the peripheral secretory organs and lymphoid tissues. PrP Sc excretes are detected in blood, urine, saliva, milk and bonemeat meal (MBM) of infected animal even at sub-clinical stage. The titre from urine and saliva of CWD infected cervid was able to reproduce infectivity in naïve cervid and transgenic mice models. [427] [428] [429] Salivary expression can contaminate drinking water and pose a risk of transmission to human and other animals. 430 Scrapie infected sheep shed PrP Sc in all components of colostrum and milk i.e. cells, cream and casein/whey proteins, which carried infectivity to lambs and dairy products. 431, 432 The titre of infectivity per mL of milk was equivalent to 6 mg of brain homogenate from terminally scrapie-infected sheep. 433 Bone and meat materials, either decaying in the soil or processed into MBM for cattle feeds, had PrP Sc attached to its particles. PrP Sc attached to MBM or soil particles had higher transmission efficiency. 434 Infectivity was retained and transmissible to animals even after processing of MBM for biodiesel productions. 435 Once attached to the soil particles, PrP Sc not detachable via surfactants and soil could retain infectivity up to 19 years. [436] [437] [438] However, hyperthermophilic bacteria were able to digest the PrP Sc particles from soil by secreting keratins and b-sheets proteases. 439 Rasmussen et al. first showed that hamster PrP Sc were able to bind with wheat grass roots, from soil and brain homogenate, but neither absorbed in roots nor detected in areal parts of the plants. 440 Pritzkow et al. used protein misfolded cyclic amplification (PMCA) as a more sensitive detection method and transmitted hamster 263K PrP Sc to wheat grass roots via infected brain homogenate, excreta, contaminated soils and direct spray of PrP on areal parts. 441 The 263K PrP Sc were able to adsorb from the sources to the roots and travelled in the areal parts, which were further able to reproduce the infectivity in naïve hamster. Apart from the extraneous PrP Sc in plants, a protein named luminidependens from Arabidopsis thaliana was transformed and propagated like PrP when injected in yeast cells. 442 
Conversion and replication of prions
The molecular interaction between PrP Sc and PrP C is based on self-assembly driven by hydrogen bonding and p-stacking of the tyrosine residues. Two initial models described the mechanism of PrP replication. 443 The ''template directed'' model described by sonication and the conversion process was amplified. 446 Makarava et al. refined the conversion phenomenon by studying the conformation switch (R and S) within single, mousehamster cross-seeded PrP amyloids and introduced the concepts of catalytic versus templated conversion and amyloid flexibility. 447 Hamster PrP (S conformation), when incubated with mouse PrP monomers, catalyzed the conversion by accelerating the fibrillation rate and shortening the lag phase, but the newly formed daughter fibrils retained R conformation only. In contrast, when hamster PrP seeds were introduced to hamster PrP monomers, it accelerated fibrillation and templated the same S conformation in daughter fibrils. Molecular events occurring in template-directed PrP conversion started from p-p interaction of PrP C and PrP Sc in 6 different binding and conversion domains (BCD) of PrP. In the absence of PrP Sc , when human and hamster PrP C BCD were probed with monoclonal antibody (mAb), it resulted in structural denaturation of PrP C , regional loss of tertiary structure, dissociation of b-sheets, and exposure of bityrosine regions (YYR) at a 1 and a 2 helices. The exposure of YYR regions was confirmed with binding of anti-YYR mAb in these lose regions. 448 In contrast to mAb, PrP Sc binding induced melting and exposure of YYR regions from b 2 -a 2 , a 2 -a 3 and a 1 regions. [448] [449] [450] The exposed YYR could be the site of further PrP C attachment and connected the oligomer and monomer. 450 The loose structure induced by mAb was not able to acquire any conformation or secondary structure from mAb. However, when PrP Sc oligomers induced this structural loosening, it acquired b-sheets from oligomer's hydrogen bonded backbone and stabilized the whole fibril column. 
Transmission barriers: sequence and conformation
A transmission barrier appears when there is no clinical neuropathology of spongiform encephalopathies upon inoculation of PrP Sc from infected species A into the naïve species B.
The molecular etiology for the transmission barrier is attributed to (i) difference in the sequences of host and donor PrP, (ii) conformational misfit during assembly, and (iii) post conversion maturation in host. with switches at 139 (M/I) and (iii) 129 (b 1 ) for M/V switch (Fig. 19) . [455] [456] [457] [458] and ended up with 22H strain. However, upon passaging the recombinant and pure 22C strain, only 22C was resulted in the host indicating the presence of both 22C and 22H in natural inoculum but 22H with shorted incubation time and close fit with host PrP was able to replicate at a faster rate. 472 Makarava et al. annealed hamster rPrP Sc with normal hamster brain homogenate and inoculated in naïve hamster. On first passage, 50% attack was observed but all hamster succumbed to disease on second passage and clinical symptoms were different from original rPrP Sc which was used to prepare the inoculum. 464 The explanation is that (i) original inoculum lacked the GPI anchor and failed to penetrate the cell to initiate neurotoxicity, (ii) conformational adaptation and stability were observed upon serial PCMA and (iii) rPrP Sc -NBH failed to acquire co-factors, which it acquired on subsequent passages in the host. 464 Serial passages of donor PrP Sc with host PrP C by PCMA in vivo or in vitro also changed the biochemical parameters like electrophoretic mobility, protease digestion and degree of glycosylation. 473 The efficiency and properties of evolutionary adaptation was also found to be tissue dependant, i.e., occurring at a faster rate in spleen than brain and cell and brain adapting different strains. 465, 474 
Toxicity of prions and mitigation
Two and a half decades on, the mechanism of prion toxicity has been narrowed down to the distortion of neuronal cell membranes due to the assembly of PrP Sc oligomers with GPI 484, 485 The adduct formed on the membrane can be internalized and disrupt endosomal trafficking or distort the local fluidity, structure and function of lipid bilayers like channel formation in GSS. 476, 486 In addition to adduct formation, PrP Sc oligomers can independently interact with membranes via their own GPI anchors, which they tend to develop during sequel passages. 487 The oligomer form of PrP Sc has been shown to be the toxic species, other than the monomers or amyloids. 480 PrP Sc oligomers possess the necessary hydrogen bonding backbone running up and own in the column to induce conformational change in PrP C and recruit the latter at the growing end. 447 PrP Sc oligomers corrupt PrP C function and deliver a neurotoxic signal. 476 Initial therapeutic strategies considered silencing of the PrP C gene. Silencing was well tolerated in animals apart from minor disturbance in sleep cycle and electrophysiology of hippocampus. 500 However, as the PrP C is associated with neuroprotection excitotoxicity outcomes are being predicted for silencing PrP C in human. 501 (Fig. 20h) . 499 Pre-treatment of PrP Sc amyloids with polyamines rendered them susceptible to proteolytic digestion. Tran et al. used polyallylamine (+) and polystyrenesulfonate (À) as two oppositely charged polyamines for layer-bylayer coating of gold NPs (AuNPs) (Fig. 20c) . The AuNPs translocated across the BBB, disrupted the PrP Sc amyloids, and mitigated the toxicity in scrapie-infected cells. Nanomolar concentrations of AuNPs, with poly(allylamine) as the outermost layer, prolonged incubation time and delayed the disease onset in infected mice. 497 Polyamine-based dendrimers coated with maltose or maltotriose stimulated PrP fibrillization at lower concentrations by breaking long fibrils into small seeds, but at higher concentrations blocked the fibrillization by stabilizing individual seeds (Fig. 20h) . (Fig. 20j) . 489, 495 PrP binding with aptamer-conjugated NPs induces controlled aggregation which can be sensed via resonance light scattering of metal NPs aggregation (Fig. 20b) . 488 Henry et al. employed fluorescence turn-on and turn-off sensing for PrP detection. 498 The fluorescence of fluorescein-GABA-QYQRES-COOH peptide bound to antibody-conjugated AuNPs (turned-off) was turned-on by replacing the peptide with competitive binding of PrP Sc with the antibody (Fig. 20a) . The fluorescence property of biotinavidin or monoclonal antibody bound quantum dots (QDs) has also been explored for the detection of PrP in vitro and in vivo (Fig. 20g) . 490 on QDs. MNPs and QDs sandwiched PrP Sc or PrP C in between and the technique was used to detect and isolate PrP by fluorescent QDs and magnetic NPs even from 0.1% infected brain homogenate (Fig. 20f) . 496 MNPs directly capped with aspartic acid or Au-mercaptopropionic acid were able to sequester PrP via carbodiimide coupling (Fig. 20d) . 505 Miller et al. (Fig. 20e) . 506 On the medicinal chemistry front, amphotericin B, 507, 508 quinacrine, dimeric analogues of statins, pyrazolones and pyridyl hydrozones are available drugs for prolonging the lifespan of PrP infected animals. 493, 509 515, 516 More in vitro and in vivo cross seeding studies are necessary to elucidate the mechanisms and relationships between these diseases of different origins.
Summary
A survey of the literature has revealed striking similarities in the cross-b motifs of amyloid fibrils held together by H-bonding, regardless of the sequence and origin of the proteins. However, a recent study reported a cross-a amyloid structure associated with PSMa3, a 22-residue functional amyloid peptide secreted by Staphylococcus aureus for inflammatory response stimulation, human cell lysis and biofilm formation, representing a surprising departure from the common amyloid structure. 517 The suprastructure of amyloid fibrils -including that of all (S) Ab 1-40 and hen egg lysozyme -has been shown as predominantly left handed, 518 originated from the inherent left-handed chirality of the (S) amino acids. However, right-handed amyloids have been reported for truncated serum amyloid A (SAA) peptides (o12 residues), resulting from the occurrence of b helices in SAA protofilaments prior to their assembly into fibrils. 519 A recent study on serum albumin amyloids, has revealed that handedness can be inverted from left to right handed, upon lateral addition of protofilaments of amyloid fibrils of a lower hierarchical level. 520 There is compelling evidence that amyloid proteins can spread from cell to cell and cross talk in vivo to either speed up or slow down aggregation of the host protein. 291, 519, [521] [522] [523] Furthermore, aggregates of non-amyloidogenic proteins, such as bovine PI3-SH3 domain and E. coli HypF domain, can serve as seeds to promote cytotoxicity in brain cells. This phenomenon suggests a generic origin of protein misfolding diseases resulting from the emergence of trace amounts of aggregates, either introduced intracellularly through misfolding or mutations or externally through cross seeding. 285 The development of neurodegenerative disorders appears to be correlated with aging, where misfolding of proteins down the free energy landscape towards the amyloid state is likely prevented by metal ions (such as Ca 2+ in the ER), molecular chaperones, ubiquitination enzymes and proteasomes, which kinetically trap the aggregating proteins off pathway. 285, 524 Compared with Ab or IAPP, the tremendous plasticity of aS and PrP may originate from their much longer chain lengths and, therefore, greater populations of misfolded intermediates. Although controversies remain, the observations that oligomers are more toxic than their fibrillar counterparts appear pervasive to amyloid proteins. In addition, oligomer-specific antibody developed for Ab also bound the oligomers of IAPP, lysozyme, prion106-126, human insulin, polyglutamine and aS, suggesting a common tertiary structure 273 as well as a common mechanism of pathogenesis beyond the individuality of the proteins and compositions of their molecular chaperones and cellular environments. As amyloid proteins fibrillate along the kinetic pathway, both their solubility and reactivity appear to decline, consequently impacting protein self-assembly and their engagement with environmental ligands, proteins, cell membranes and organelles to elicit toxicity. While such conditions can be manipulated in vitro, such as through the regulation of temperature and pH or the introduction of metal ions, small molecules or engineered NPs, how to create in vivo conditions that prohibit trace amounts of aggregates from activating primary and/or secondary nucleation remains a tremendous challenge. Despite the complexity of protein structure, function and toxicity, as revealed by intensive research spanning the past two decades and highlighted in this review, protein aggregation through self-assembly and interaction with cellular environments constitutes hallmarks of neuronal and pancreatic b-cell degeneration. Consequently, understanding and exploiting molecular assembly under physiological conditions could make inroads on the development of therapeutics and diagnostics against amyloid diseases. 
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